Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maleic Hydrazide SCHEMBL55070 | 0.96 | CYP1A2 (0.44) | CYP1A2TSHRNFKB1MAOAMAOB | |
| Maleic Hydrazide SCHEMBL466482 | 0.96 | CYP1A2 (0.44) | CYP1A2TSHRNFKB1MAOAMAOB | |
| Maleic Hydrazide SCHEMBL28265377 | 0.96 | CYP1A2 (0.44) | CYP1A2TSHRNFKB1MAOAMAOB | |
| Maleic Hydrazide SCHEMBL1534936 | 0.96 | CYP1A2 (0.44) | CYP1A2TSHRNFKB1MAOAMAOB | |
| Maleic Hydrazide SCHEMBL408266 | 0.93 | CYP1A2 (0.41) | CYP1A2TSHRNFKB1MAOAMAOB | |
| Maleic Hydrazide SCHEMBL9489247 | 0.93 | CYP1A2 (0.41) | CYP1A2TSHRNFKB1MAOAMAOB | |
| Maleic Hydrazide SCHEMBL7116620 | 0.93 | CYP1A2 (0.41) | CYP1A2TSHRNFKB1MAOAMAOB | |
| Maleic Hydrazide SCHEMBL30239213 | 0.93 | CYP1A2 (0.41) | CYP1A2TSHRNFKB1MAOAMAOB | |
| Maleic Hydrazide SCHEMBL28280739 | 0.90 | CYP1A2 (0.39) | CYP1A2TSHRNFKB1MAOAMAOB | |
| SCHEMBL28797787 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103250578-B | Method utilizing sprout inhibition agent to control phytoplasma jujube with broom disease and phytoplasma paulownia withes broom disease of plants | ZHOU XUESHANG | 2015-04-08 | — | — | CN | claimed |
| CN-103250578-A | Method utilizing sprout inhibition agent to control phytoplasma jujube withes broom disease and phytoplasma paulownia withes broom disease of plants | ZHOU XUESHANG | 2013-08-21 | — | — | CN | claimed |
| WO-2025078992-A1 | METHOD OF CONTROLLING WEEDS | UPL MAURITIUS LIMITED (MU) | 2025-04-17 | — | — | WO | disclosed |
| US-20240188560-A1 | STABLE EMULSIONS | ADAMA AGAN LTD. (IL) | 2024-06-13 | — | — | US | disclosed |
| CN-103250578-B | Method utilizing sprout inhibition agent to control phytoplasma jujube with broom disease and phytoplasma paulownia withes broom disease of plants | ZHOU XUESHANG | 2015-04-08 | — | — | CN | disclosed |
| CN-103250578-A | Method utilizing sprout inhibition agent to control phytoplasma jujube withes broom disease and phytoplasma paulownia withes broom disease of plants | ZHOU XUESHANG | 2013-08-21 | — | — | CN | disclosed |
| WO-1999026885-A1 | COMPOSITIONS AND METHODS FOR ADSORPTION AND REMEDIATION OF ORGANIC COMPOUNDS | UNIVERSITY OF FLORIDA (US) | 1999-06-03 | — | — | WO | disclosed |
| EP-0134339-B1 | HERBICIDAL COMPOSITION | JAPAN HYDRAZINE CO., LTD. (JP) | 1987-10-21 | — | — | EP | disclosed |
| EP-0134339-A1 | Herbicidal composition | JAPAN HYDRAZINE CO., LTD. (JP) | 1985-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240188560-A1 | STABLE EMULSIONS | POLR2H, POLR2E, PHOSPHO1 | CYP1A2 2628/4885TSHR 1862/4885NFKB1 1550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.